The reductive activation of artemisinin (or artemether) by ferroprotoporphy
rin-IX, the prosthetic group of hemoglobin, is able to produce covalent add
ucts heme-artemisinin in high yield under very mild conditions. This adduct
formation, using the natural target of an endoperoxide antimalarial drug,
confirms the alkylating ability of this class of antimalarial drugs, which
has already been reported when using a synthetic manganese porphyrin. (C) A
cademie des sciences / Editions scientifiques et medicales Elsevier SAS.